As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (GAAP) are increasingly recognized as meaningful signals of ...

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for ...

Eli Lilly has been on a dealmaking spree this year, with a few deals worth $1 billion or more. Aside from SangeneBio, these include SiteOne, Verve and Scorpion. Eli Lilly has put $1.2 billion on the ...

MeiraGTx Holdings is licensing a genetic eye disease medicine to Eli Lilly in a deal worth up to $475 million. Eli Lilly’s business development team has been busy this weekend. The GLP-1 pharma has ...

Is It Safe To Clean Your Dishes The 'British Way'? Health Experts Explain Coast Guard announces largest cocaine seizure in agency history She Gave Her Triplets Nearly Identical Names. And Yes, It's ...

Emu runs after canine pals during a playful game of chase Kim Kardashian misses the mark on the California bar exam, vows to keep trying Former TV anchor charged with first-degree murder in stabbing ...

Eli Lilly and Co.’s amylin receptor agonist, eloralintide, showed impressive weight loss and improved tolerability in phase II results reported at ObesityWeek 2025, setting the stage for a phase III ...

Hailing it as a win-win and a historic step forward in fighting chronic disease, the Trump administration announced pricing agreements Nov. 6 with Eli Lilly and Co. and Novo Nordisk A/S that will ...

Eli Lilly is going for gold at the Milano Cortina 2026 Olympic and Paralympic Winter Games. In a pair of recent announcements, the Big Pharma was named an official sponsor of the Games, while also ...

Neok Bio emerged from stealth on Tuesday with $75 million in Series A funding and plans to develop what it claims are “differentiated” antibody-drug conjugates, or ADCs, that can overcome the ...

In an announcement Monday, Nov. 3, the Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines. Lilly expects to ...